source
- Dr Mauro on the Significance of Alternative TKI Formulations in CMLMichael Mauro, MD, details the FDA approval of the small-molecule formulation of dasatinib and other alternate TKI formulations in chronic myeloid leukemia.onclive · 2mo ago↗ source
- Sarepta tumbles as its gene therapy sales decline furtherEven though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta's early-stage RNA drugs.BioPharma Dive · 2mo ago↗ source
- Women With Bladder Cancer Face Diagnostic Delays as Symptoms Mimic UTIs, Experts WarnTimothy N. Clinton, MD, and Stephanie A. Berg, DO, discuss gender differences in bladder cancer during Bladder Cancer Awareness Month.onclive · 2mo ago↗ source